Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma

NCT04930653 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Folliculotropic Mycosis Fungoides
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Sezary Syndrome
Stage IB Mycosis Fungoides and Sezary Syndrome AJCC v8
Stage II Mycosis Fungoides and Sezary Syndrome AJCC v8
Stage IIA Mycosis Fungoides and Sezary Syndrome AJCC v8
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
Transformed Mycosis Fungoides

Interventions

PROCEDURE: Extracorporeal Photopheresis
BIOLOGICAL: Mogamulizumab
OTHER: Quality-of-Life Assessment
OTHER: Questionnaire Administration

Sponsor

City of Hope Medical Center

Collaborators

[object Object]